Spiller av onsdag 13. november 2002

13. november 2002 var en onsdag under stjernetegnet til . Det var 316 dagen i året. President i USA var George W. Bush.

Hvis du ble født på denne dagen, er du 23 år gammel. Den siste bursdagen din var på torsdag 13. november 2025, 206 dager siden. Din neste bursdag er fredag 13. november 2026, om 158 dager. Du har bodd i 8 607 dager, eller omtrent 206 590 timer, eller omtrent 12 395 436 minutter, eller omtrent 743 726 160 sekunder.

Noen personer som deler denne bursdagen:

13th of November 2002 News

Nyheter slik de dukket opp på forsiden av New York Times på 13. november 2002

Metro Briefing: New York

Date: 13 November 2002

NIAGARA FALLS: Senecas Get $80 Million Casino Loan; MANHATTAN: 20 Indicted In Mob Inquiry; HEMPSTEAD: Not-Guilty Plea In Fatal Quarrel; BROOKLYN: Man Sentenced For Fooling Drivers; SYRACUSE: Megamall Advances;.

Full Article

Sports of The Times; Protesters Are Next Act To Appear at 'the Hootie'

Date: 14 November 2002

By Dave Anderson

Dave Anderson

Dave Anderson Sports of The Times column contends that Augusta National Golf Club chairman William 'Hootie' Johnson has turned storied Masters Tournament into circus as his bold and brazen decisions attract media attention; photo (M)

Full Article

GROCERY DISTRIBUTOR SAYS IT IS SUBJECT OF S.E.C. INQUIRY

Date: 14 November 2002

By Bloomberg News

Bloomberg News

Securities and Exchange Commission conducts informal investigation into sales and accounting practices of Fleming Companies, nation's largest grocery distributor; separately, company says it will sell 28 of its California grocery stores to Save Mart Supermarkets for as much as $130 million (S)

Full Article

DANONE TO PURCHASE SPARKLING SPRING WATER OF CANADA

Date: 13 November 2002

By Bloomberg News

Bloomberg News

Groupe Danone agrees to buy Sparkling Spring Water Holdings of Canada (S)

Full Article

BOEING ENGINEERS TO VOTE ON 3-YEAR CONTRACT

Date: 14 November 2002

By Bloomberg News

Bloomberg News

Boeing Co engineers represented by Society of Professional Engineering Employees in Aerospace will vote to recommend three-year contract that gives them annual raises of 4 percent and requires them to pay more for some health insurance plans; company anticipates 25 percent drop in deliveries of commercial jets during 2003 (S)

Full Article

UAL BOARD APPROVES TENTATIVE CONCESSION PLANS

Date: 13 November 2002

By Bloomberg News

Bloomberg News

UAL Corp approves tentative proposals by United Airlines pilots and flight attendants to reduce labor costs by $2.6 billion to help keep carrier out of bankruptcy (S)

Full Article

ALLSTATE CUTS PROFIT AFTER ASBESTOS ACCORD

Date: 14 November 2002

By Bloomberg News

Bloomberg News

Allstate Corp settles asbestos claim requiring it to delete $32 million from profit it reported in October; believes its reserves for asbestos litigation are adequate (S)

Full Article

PATHMARK SHARES PLUNGE AFTER WARNING ON EARNINGS

Date: 14 November 2002

By Bloomberg News

Bloomberg News

Pathmark Stores warns that its fiscal fourth-quarter results will be lower than it forecast; stock price plunges 23 percent (S)

Full Article

CANCER DRUG COMPANY ACQUIRES STEM CELL TECHNOLOGY

Date: 14 November 2002

By Bloomberg News

Bloomberg News

Celgene Corp agrees to pay $45 million in stock to acquire Anthrogenesis Corp and gain its technology for harvesting stem cells that may be used for cancer treatments (S)

Full Article

INCYTE TO CUT 37 PERCENT OF WORKERS AND CLOSE OFFICES

Date: 13 November 2002

By Bloomberg News

Bloomberg News

Incyte Genomics, provider of genetic information to pharmaceutical manufacturers, will lay off 37 percent of its 700 employees and close some offices to save $88 million annually (S)

Full Article

DRUG PRODUCER SAYS IT MAY MISS 2002 REVENUE GOAL

Date: 14 November 2002

By Bloomberg News

Bloomberg News

Shares of Ligand Pharmaceuticals fall 26 percent after company says it may not meet its 2002 revenue goal; discloses news on Nov 12 when it reported $7 million third-quarter loss (S)

Full Article

JOHNSON & JOHNSON TO BUY DRUG MAKER FOR $110 MILLION

Date: 14 November 2002

By Bloomberg News

Bloomberg News

Johnson & Johnson agrees to purchase OraPharma for about $110 million to increase its share of market for medicines that treat diseases of mouth; OraPharma shareholders will receive $7.41 for each share held, 63 percent premium over its Nov 12 closing price (S)

Full Article